Prepare Before the Inspection
Identify evidence gaps, prepare SMEs, test inspection-response workflows and prioritize the issues most likely to influence regulatory outcomes.
Independent, risk-based audit and inspection support for regulated life sciences organizations requiring stronger compliance visibility, credible assurance, inspection readiness and practical remediation priorities.
The Inspection & Audit portfolio is designed to support organizations before, during and after high-stakes regulatory or client scrutiny, with clear findings and practical next steps.
Identify evidence gaps, prepare SMEs, test inspection-response workflows and prioritize the issues most likely to influence regulatory outcomes.
Evaluate how procedures, responsibilities, oversight and quality systems operate in practice, not only how they are described in documentation.
Translate observations into risk-ranked actions that support remediation, leadership decisions and sustainable quality improvement.
Select a service to explore the engagement scope, deliverables, business value and support available for your organization.
Structured preparation for regulatory, sponsor and client inspections, including readiness assessments, mock inspections, evidence review, SME preparation and inspection-response planning.
Independent clinical quality audits covering participant protection, protocol compliance, sponsor oversight, CRO performance, trial documentation and data reliability.
Independent audits of nonclinical study conduct, raw data, laboratory processes, computerized systems, equipment controls and quality assurance oversight.
Risk-based audits of manufacturing, laboratory, documentation, supplier and quality system controls supporting product quality and regulatory compliance.
Independent assessment of pharmacovigilance systems, safety case management, signal processes, partner oversight and compliance with safety reporting responsibilities.
Qualification and oversight audits for CROs, laboratories, technology providers, manufacturers, consultants and other critical suppliers supporting regulated activities.
Independent review of Trial Master File completeness, quality, timeliness, traceability and inspection readiness across paper, electronic and hybrid environments.
Evaluation of ALCOA+ practices, audit trails, access controls, electronic records, computerized system governance and data lifecycle controls.
Targeted investigations and focused compliance reviews when serious concerns, repeat findings, deviations or potential systemic failures require independent evaluation.
Design and optimization of risk-based internal and external audit programs aligned with organizational priorities, regulatory exposure and vendor risk.
Audit findings are most valuable when they improve visibility, strengthen leadership decisions and help the organization focus resources on the risks with the highest regulatory and operational impact.
Identify weaknesses in records, systems, governance and oversight before they become regulatory observations or repeat findings.
Prepare teams, evidence and leadership to demonstrate that regulated processes are understood, controlled and supported by reliable data.
Prioritize systemic and high-risk issues so corrective actions target the real causes of compliance exposure.
Engagements can be adapted for planned audit programs, urgent inspection preparation, focused risk reviews or independent investigation support.
Understand the organization, regulated activity, business objective, known quality risks and inspection or audit exposure.
Define audit criteria, sites, functions, systems, vendors, stakeholders, timing and expected deliverables.
Conduct interviews, walkthroughs, document review, record sampling and evaluation of operational and quality controls.
Deliver clear findings, risk classification, executive insight and practical recommendations for remediation.
Independent audit support can be used proactively, as part of routine governance, or urgently when significant compliance risk becomes visible.
An authority inspection has been announced and rapid readiness assessment is required.
A critical supplier or service provider must be assessed before engagement or renewal.
Similar deviations, CAPAs or audit observations indicate a possible systemic weakness.
New teams, sites, systems or vendors have increased quality and oversight complexity.
Electronic records, audit trails, raw data or documentation practices require independent review.
A partner, acquisition target or investment requires quality and compliance assurance.
Leadership needs an independent view of audit strategy, quality maturity and risk coverage.
A serious event requires focused, confidential and independent assessment.